Metabolic
AOD-9604
per administration
It has been used in people, but no trial has settled how much or how often.
The human evidence for AOD-9604 used the oral route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.
Quick start
AOD-9604 at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 250–500 mcg per administration
- How often
- Every day
- Where
- Oral
- Time to steady level
- ~2 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Key properties
Molecular reference data.
- Formula
- C78H123N23O23S2
- Mol. weight
- 1,815.1 Da
- CAS
- 221231-10-3
- PubChem CID
- 71300630
External references
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for AOD-9604 describe 250–500 mcg per administration. Descriptive only, not a recommendation.
Roughly 20-30 minutes in published work.
The two human trials of AOD-9604 were oral and one failed at every amount; the subcutaneous figures in circulation are community-derived, not the trial amounts, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 2hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- AOD-9604 obesity study (Metabolic Pharmaceuticals)A phase-2 oral study of the hGH fragment did not separate from placebo on weight.